Business Wire

  1. Applied Biosystems Launches Service Provider Program For Real-Time RNA Expression Analysis 9/16/2008
    Applied Biosystems Inc. today announced that it has established a global service provider program for RNA expression analysis.
  2. Geron Announces Issuance Of U.S. Patent For Cardiomyocytes From Human Embryonic Stem Cells 9/16/2008
    Geron Corporation today announced the issuance of U.S. Patent No. 7,425,448, with broad claims to cardiomyocytes derived from human embryonic stem cells (hESCs).
  3. IPS Announces Winners Of “What A Waste” Contest 9/16/2008
    Integrated Project Services (IPS),today announced the winners of the company’s “What a Waste” Contest. Sponsored by the IPS Sustainable Leadership Team, the contest was developed to collect ideas for practical conservation and sustainability, material and waste reduction, and recycling or alternate uses of spent resources.
  4. The Genome Institute Of Singapore Acquires Applied Biosystems Genomic Analysis Systems For Cancer Research 9/15/2008
    Applied Biosystems announced today that GIS will add three new SOLiD™ Systems to its existing base of genomics analysis technologies.
  5. Applied Biosystems Expands Sequencing-Based RNA Analysis Solutions Portfolio 8/26/2008
    Applied Biosystems Inc. (NYSE:ABI) today announced the development of a sequencing-based molecular tool for the genomic analysis of whole transcriptomes, the vast collection of RNAs transcribed from a genome
  6. BioTime, Inc.'s Subsidiary, Embryome Sciences, Inc., Licenses Virus-Free iPS And Embryonic Stem Cell Differentiation Technology 8/21/2008
    Embryome Sciences, Inc., a wholly owned subsidiary of BioTime, Inc. (OTCBB:BTIM), announced today the license of a portfolio of patents and patent applications from Advanced Cell Technology, Inc. (“ACT”) relating to induced pluripotent stem cells (“iPS”) and embryonic stem cell differentiation technology
  7. STEMCELL Technologies Introduces AggreWell™400 For Standardized Embryonic Stem Cell And Induced Pluripotent Stem Cell Research 8/20/2008
    STEMCELL Technologies, a leader in specialty cell culture media, cell separation products and ancillary reagents for stem cell research, today announced the release of the AggreWell™400 plates, a revolutionary tool for researchers using embryonic and induced pluripotent stem cells (ESC and iPSC)
  8. Invitrogen Launches Legionella Test To Streamline Surveillance 8/19/2008
    Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today the launch of its Dynabeads® MAX Legionella, which enables a unique process for targeting and concentrating legionella from environmental water samples
  9. Asuragen, Inc. Launches Signature® NPM1 Mutations (RUO)*: A Rapid Multiplex Assay For The Detection Of NPM1 Mutations 8/18/2008
    Asuragen, Inc. announced today the launch of Signature® NPM1 Mutations (RUO), a multiplex reverse transcription PCR (RT-PCR) assay that enables the detection of NPM1 mutations
  10. Immune Response To Human Embryonic Stem Cells In Mice Suggests Human Therapy May Face Challenge, Stanford Study Shows 8/18/2008
    Human embryonic stem cells trigger an immune response in mice, researchers from the Stanford University School of Medicine report